REGN

STRONG BUY

Regeneron Pharmaceuticals, Inc.

Healthcare · Rank #4 · Analyzed Oct 18, 2026

$790.74

Current Price

$1514.65

Intrinsic Value

+91.5%

Upside/Downside

9.9/10

Score

4/5

Quality

Analysis Summary

Valuation Consensus2/3 methods agree

Quality Score4/5.0

Framework RatingSTRONG BUY

Price vs Intrinsic ValueUndervalued by 91.5%

Fair Value Range

Low$237.30

Base (IV)$1514.65

High$1870.65

Entry Points

Conservative$166.11

Moderate$237.30

Aggressive$1060.26

Quality & Moat Breakdown

Return on Equity14.0% → 0.5/1.0

Debt LevelD/E 9 → 1.0/1.0

Revenue QualityGrowth 6.6%, margin Δ-38.0% +recovery → 1.0/1.0

Moat Strength3.0/5 → 0.5/1.0

Profit Margins27.9% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.